title: Phase II study of everolimus in metastatic urothelial cancer.
authors.forename: Angela B
authors.initials: AB
authors.lastname: Smith
authors.forename: Raj S
authors.initials: RS
authors.lastname: Pruthi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000556:secondary; D017322:Clinical Trials, Phase II as Topic; D000068338:Everolimus; D006801:Humans; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D000068338:Everolimus; D020123:Sirolimus